These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29274818)

  • 21. Population pharmacokinetics of ceftazidime in burn patients.
    Dailly E; Pannier M; Jolliet P; Bourin M
    Br J Clin Pharmacol; 2003 Dec; 56(6):629-34. PubMed ID: 14616422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms.
    Shoji K; Bradley JS; Reed MD; van den Anker JN; Domonoske C; Capparelli EV
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2150-6. PubMed ID: 26810655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation.
    Conil JM; Georges B; Lavit M; Laguerre J; Samii K; Houin G; Saivin S
    Br J Clin Pharmacol; 2007 Jul; 64(1):27-35. PubMed ID: 17324245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.
    Pullen J; Stolk LM; Nieman FH; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Apr; 28(2):226-31. PubMed ID: 16628135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration.
    Li X; Sun S; Ling X; Chen K; Wang Q; Zhao Z
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1599-1607. PubMed ID: 28849406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic modeling and simulation for dose rationale of doripenem in neonates and infants.
    Matsuo Y; Matsumoto S; Wajima T; Matsubara K
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):145-150. PubMed ID: 31969257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.
    Chen Y; Lu J; Dong M; Wu D; Zhu Y; Li Q; Chen C; Li Z
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1479-1488. PubMed ID: 27644691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Maternal and Neonatal Pharmacokinetic Behavior of Ceftazidime.
    Dallmann A; van den Anker J; Pfister M; Koch G
    J Clin Pharmacol; 2019 Jan; 59(1):74-82. PubMed ID: 30113711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates.
    Matcha S; Dillibatcha J; Raju AP; Chaudhari BB; Moorkoth S; Lewis LE; Mallayasamy S
    Paediatr Drugs; 2023 May; 25(3):365-375. PubMed ID: 36943583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis.
    Bensman TJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of ceftazidime after intravenous and intramuscular administration to domestic cats.
    Albarellos GA; Ambros LA; Landoni MF
    Vet J; 2008 Nov; 178(2):238-43. PubMed ID: 17768077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics and dosage optimization of linezolid in Chinese older patients.
    Li Y; Fang Q; Wu Z; Huang S; Ge W; Shen J; Zhu H
    Eur J Clin Pharmacol; 2024 Sep; 80(9):1295-1304. PubMed ID: 38801422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis.
    Xu H; Zhou W; Zhou D; Li J; Al-Huniti N
    J Clin Pharmacol; 2017 Mar; 57(3):336-344. PubMed ID: 27530649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children.
    Yoshizawa K; Ikawa K; Ikeda K; Ohge H; Morikawa N
    Pediatr Infect Dis J; 2013 Nov; 32(11):1208-16. PubMed ID: 23676856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. POPULATION PHARMACOKINETICS OF CEFTAZIDIME AFTER A SINGLE SUBCUTANEOUS INJECTION AND NORMAL ORAL AND CLOACAL BACTERIAL FLORA SURVEY IN EASTERN HELLBENDERS (
    Musgrave KE; Hanley CS; Papich MG
    J Zoo Wildl Med; 2021 Apr; 52(1):90-96. PubMed ID: 33827165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Pharmacokinetics and Dosing Considerations for Gentamicin in Newborns with Suspected or Proven Sepsis Caused by Gram-Negative Bacteria.
    Bijleveld YA; van den Heuvel ME; Hodiamont CJ; Mathôt RA; de Haan TR
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill Patients.
    Mathew SK; Mathew BS; Neely MN; Naik GS; Prabha R; Jacob GG; K S; Fleming DH
    Ther Drug Monit; 2016 Oct; 38(5):593-9. PubMed ID: 27454665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.